ADVOCACY FOR IMPACT Trademark

Trademark Overview

On Friday, September 21, 2018, a trademark application was filed for ADVOCACY FOR IMPACT with the United States Patent and Trademark Office. The USPTO has given the ADVOCACY FOR IMPACT trademark a serial number of 88126473. The federal status of this trademark filing is REGISTERED as of Tuesday, December 28, 2021. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The ADVOCACY FOR IMPACT trademark is filed in the Insurance & Financial Services category with the following description:

Providing grants to patient advocacy groups in support of projects that will have an effect on rare diseases; conducting a competitive grants program, namely, providing grants for patient advocacy groups; charitable services, namely, granting funds to support projects directed to rare diseases
advocacy for impact

General Information

Serial Number88126473
Word MarkADVOCACY FOR IMPACT
Filing DateFriday, September 21, 2018
Status700 - REGISTERED
Status DateTuesday, December 28, 2021
Registration Number6603392
Registration DateTuesday, December 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesProviding grants to patient advocacy groups in support of projects that will have an effect on rare diseases; conducting a competitive grants program, namely, providing grants for patient advocacy groups; charitable services, namely, granting funds to support projects directed to rare diseases

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, September 27, 2018
Primary Code036
First Use Anywhere DateWednesday, October 24, 2018
First Use In Commerce DateWednesday, October 24, 2018

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Thursday, March 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 28, 2021REGISTERED-PRINCIPAL REGISTER
Saturday, November 20, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 19, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, October 22, 2021USE AMENDMENT FILED
Friday, October 29, 2021SOU EXTENSION 5 GRANTED
Friday, October 22, 2021SOU EXTENSION 5 FILED
Friday, October 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 22, 2021TEAS EXTENSION RECEIVED
Wednesday, October 13, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 22, 2021SOU EXTENSION 4 GRANTED
Thursday, April 22, 2021SOU EXTENSION 4 FILED
Thursday, April 22, 2021TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 23, 2020SOU EXTENSION 3 GRANTED
Friday, October 23, 2020SOU EXTENSION 3 FILED
Friday, October 23, 2020TEAS EXTENSION RECEIVED
Saturday, April 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 23, 2020SOU EXTENSION 2 GRANTED
Thursday, April 23, 2020SOU EXTENSION 2 FILED
Thursday, April 23, 2020TEAS EXTENSION RECEIVED
Friday, October 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 23, 2019SOU EXTENSION 1 FILED
Wednesday, October 23, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 24, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 24, 2019ASSIGNED TO LIE
Wednesday, January 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 9, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, January 9, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 9, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, January 9, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, January 4, 2019ASSIGNED TO EXAMINER
Thursday, September 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 25, 2018NEW APPLICATION ENTERED

Related Keywords

impact advocacy grants providing diseases namely projects rare support patient groups